Invesco Ltd. Aravive, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$4.65 - $6.42 $53,484 - $73,842	-11,502 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.11 - $9.24 $1,701 - $3,076	333 Added 2.98%	11,502 $76,000
Q4 2020 Feb 16, 2021	BUY	$4.36 - $6.51 $48,696 - $72,710	11,169 New	11,169 $63,000
Q3 2020 Nov 16, 2020	SELL	$4.7 - $12.06 $69,169 - $177,487	-14,717 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$5.18 - $14.81 $10,271 - $29,368	-1,983 Reduced 11.87%	14,717 $171,000
Q1 2020 May 15, 2020	BUY	$3.5 - $13.77 $58,450 - $229,959	16,700 New	16,700 $96,000

28.1K

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.